期刊文献+

卡介苗联合丝裂霉素膀胱灌注对膀胱癌复发及相关细胞因子表达的影响 被引量:5

Effects of intravesical instillation with BCG and mitomycin on recurrence and cytokines in patients with bladder cancer
原文传递
导出
摘要 目的探讨卡介苗联合丝裂霉素膀胱灌注对膀胱癌复发及相关细胞因子表达的影响。方法膀胱癌患者56例,术后随机均分为两组:对照组仅给予卡介苗膀胱灌注;试验组采用卡介苗联合丝裂霉素膀胱灌注。比较两组血清细胞因子表达、不良反应、2年复发率及首次复发时间。结果试验组血清IL-2、TNF-α和IFN-γ水平高于对照组(P<0.05),血清IL-10水平低于对照组(P<0.05)。试验组不良反应发生率低于对照组(32.1%vs.82.1%)(P<0.05)。试验组生活质量稳定率高于对照组(82.1%vs.57.1%)(P<0.05)。试验组2年复发率低于对照组(14.3%vs.39.3%)(P<0.05);试验组首次复发时间长于对照组(P<0.05)。结论与单用卡介苗比较,卡介苗联合丝裂霉素膀胱灌注更能有效预防膀胱癌术后复发。 Objective To investigate the effects of intravesical instillation with Bacillus Calmette-Guérin(BCG)and mitomycin on the recurrence and cytokines in the patients with bladder cancer.Methods Fifty-six patients with bladder cancer after surgery were treated with intravesical instillation with BCG plus mitomycin(group A,28cases)or with BCG instillation alone(group B,28cases).The expressions of cytokines,adverse effects,recrudescence rate in two years and the time for the first recurrence of bladder cancer were compared between two groups.Results Compared to group B,group A had higher serum levels of IL-2,TNF-αand IFN-γ(P〈0.05),lower IL-10expression(P〈0.05),lower incidence of adverse effects(32.1% vs.82.1%)(P〈0.05),and higher stability rate of living quality(82.1% vs.57.1%)(P〈0.05).The recrudescence rate in two years was lower in group A than that in group B(14.3% vs.39.3%)(P〈0.05).The time for the first recurrence of bladder cancer was longer in group A than that in group B(P〈0.05).Conclusion Combined with mitomycin can more effectively reduce the postoperative recurrence of bladder cancer than intravesical instillation with BCG alone.
出处 《江苏医药》 CAS 2016年第17期1908-1910,共3页 Jiangsu Medical Journal
基金 南通市人才工作专项资金(W201208) 南通市社会事业科技创新与示范计划(HS2013023)
关键词 膀胱癌 丝裂霉素 卡介苗 细胞因子 Bladder cancer Mitomycin Bacillus Calmette-Guérin Cytokines
  • 相关文献

参考文献12

  • 1Burger M,Catto JW,Dalbagni G,et al.Epidemiology and risk factors of urothelial bladder cancer[J].Eur Urol,2013,63(2):234-241.
  • 2Ito A,Shintaku I,Satoh M,et al.Prospective randomized phaseⅡtrial of a single early intravesical instillation of pirarubicin(THP)in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma:the THP Monotherapy Study Group Trial[J].J Clin Oncol,2013,31(11):1422-1427.
  • 3Redelman-Sidi G,Iyer G,Solit DB,et al.Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells[J].Cancer Res,2013,73(3):1156-1167.
  • 4Evers PD,Logan JE,Sills V,et al.Karnofsky performance status predicts overall survival,cancer-specific survival,and progression-free survival following radical cystectomy for urothelial carcinoma[J].World J Urol,2014,32(2):385-391.
  • 5Liu H,Wu J,Xue S,et al.Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscleinvasive bladder cancer[J].J Int Med Res,2013,41(4):984-992.
  • 6Zengin K,Tanik S,Sener NC,et al.The effect of postoperative intravesical BCG and mitomycin C therapy on recurrence of non-muscle invasive bladder cancer[J].World J Nephrol Urol,2013,2(2):65-69.
  • 7Redelman-Sidi G,Iyer G,Solit DB,et al.Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells[J].Cancer Res,2013,73(3):1156-1167.
  • 8Brausi M,Oddens J,Sylvester R,et al.Side effects of Bacillus Calmette-Guérin(BCG)in the treatment of intermediate-and high-risk Ta,T1papillary carcinoma of the bladder:results of the EORTC genito-urinary cancers group randomised phase 3study comparing one-third dose with full dose and 1year with3years of maintenance BCG[J].Eur Urol,2014,65(1):69-76.
  • 9宁金卓,姜书传.卡介苗联合药物较卡介苗灌注预防膀胱肿瘤术后复发效果的系统评价[J].辽宁医学院学报,2013,34(1):52-55. 被引量:7
  • 10杜世浩,张锦洪,曹晓建.丝裂霉素C局部应用对SD大鼠坐骨神经组织形态学及超微结构的影响[J].江苏医药,2012,38(12):1389-1392. 被引量:1

二级参考文献45

共引文献9

同被引文献45

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部